Current leakage detection

• US 9,238,140 B2
• Filed: 08/24/2007
• Issued: 01/19/2016
• Est. Priority Date: 08/25/2006
• Status: Active Grant

• Current Assignee: Cochlear Limited
• Original Assignee: Cochlear Limited
• Inventors: Moghe, Yashodhan, Eder, Helmut Christian
• Primary Examiner(s): Flory, Christopher A
• Application Number:
  US12/438,942
• Publication Number:
  US 20120191160A1
• Time in Patent Office: 3,070 Days
• Field of Search: 607/2, 607/57, 607/137, 607/27, 323/315
• US Class Current: 1/1
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: G01R 19/0092 measuring current only all subgroups of G01R19/00 take precedence
• CPC Class Codes: G01R 31/52 Testing for short-circuits, leakage current or ground faults

Abstract

An improved arrangement for detecting DC current leakage in implanted devices is disclosed. Currents are monitored, so that any unexpected imbalance indicates that a fault condition has occurred. The principle of the system is that if everything working correctly, the same current should be flowing into the tissue from VDDH-ELEC as is passing out of the tissue into VSS_ELEC. Any difference is indicative of current flowing into or out of the tissue from unknown paths, which is indicative of some fault. This replaces routine monitoring for specific faults.

Claims

1. A method of detecting DC current leakage from an electrical circuit of a device implantable in a recipient to tissue of the recipient, the device being configured to conduct current through at least one conductive path having multiple segments including a segment formed by tissue of the recipient, said method including at least the steps of:

mirroring, for each conductive path, a pre-tissue current and a post-tissue current representing currents at opposite ends of the tissue segment;

combining the pre-tissue and post-tissue currents to represent a total current;

determining whether the total current is within a desired tolerance of zero;

wherein if the total current is not within said desired tolerance of zero, determining that leakage current is present.

2. The method according to claim 1, wherein the mirroring uses current mirroring devices.

3. The method according to claim 2, wherein each current mirroring device uses one of a bipolar current mirror and a MOS current mirror.

4. The method according to claim 1, wherein the implantable device is an implantable hearing device.

5. The method according to claim 4, wherein the implanted device is a cochlear implant and the segments include electrodes of the cochlear implantable.

6. The method according to claim 1, wherein if it is determined that current leakage is present, the method further includes the step of triggering a software diagnostic process.

7. The method according to claim 1, wherein if it is determined that current leakage is present, the method further includes the step of providing an indication of the current leakage.

8. A method of detecting DC current leakage from a device implantable in a recipient to tissue of the recipient, the device being configured to conduct current through at least one conductive path having multiple segments including segments formed by a power rail, a ground rail, and a segment therebetween formed by tissue of the recipient, said method including at least the steps of:

setting a pre-tissue DAC-code for a first current-output digital-to-analog converter (current DAC) that indirectly represents a current at one end of the tissue segment;

setting a post-tissue DAC-code for a second current DAC that indirectly represents a current at the other end of the tissue segment;

using the first current DAC to adjust current at the one end of the tissue segment based on the pre-tissue DAC-code;

using the second current DAC to adjust current at the other one end of the tissue segment based on the post-tissue DAC-code;

comparing the pre-tissue DAC-code and the post-tissue DAC-code; and

if there is an absolute difference greater than a desired tolerance between the pre-tissue code and the post-tissue code, determining that current leakage is present.

9. The method according to claim 8, wherein the implantable device is an implantable hearing device.

10. The method according to claim 9, wherein the implantable device is a cochlear implant.

11. The method according to claim 8, wherein:

the implantable device includes a power rail and a counterpart ground rail;

the setting a pre-tissue code includes;

measuring voltage on the power rail;

comparing the power rail voltage against a first desired value to produce a first adjustment signal; and

generating the pre-tissue code based on the first adjustment signal; and

the setting a post-tissue code includes;

measuring voltage on the ground rail;

comparing the ground rail voltage against a second desired value to produce a second adjustment signal; and

generating the post-tissue code based on the second adjustment signal.

12. The method according to claim 8, wherein if it is determined that current leakage is present, the method further includes at least one of the following steps:

triggering a software diagnostic process; and

providing an indication of the current leakage.

13. A device, implantable in a recipient, comprising:

electrical output driving circuits powered by a respective power and ground rail, each driving circuit being configured to conduct current through a conductive path having multiple segments including segments formed by the power and ground rails, and a segment therebetween formed by tissue of the recipient;

a first current mirror, connected to a proxy node, for tracking a mirrored pre-tissue current, representing a first current passing through the power rail and at least indirectly representing a current at one end of the tissue segment;

a second current mirror, connected to the proxy node, for tracking a mirrored post-tissue current, representing a second current passing through the ground rail and at least indirectly representing a current at the other end of the tissue segment;

a resistor having a first side connected to the proxy node; and

a comparator for comparing the voltages on the first side and a second side of the resistor, such that if the comparator detects a difference greater than a desired tolerance, an indication is provided that current leakage is occurring.

14. The implantable device according to claim 13, wherein the implantable device is an implantable hearing device.

15. The implantable device according to claim 14, wherein the implantable device is a cochlear implant.

16. The implantable device according to claim 13, wherein:

each current mirror is one of a bipolar current mirror and a MOS current mirror.

17. A device, implantable in a recipient, comprising:

a first DAC-code generator configured to generate a pre-tissue DAC-code that indirectly represents a current at one end of the tissue segment;

a second DAC-code generator configured to generate a post-tissue DAC-code that indirectly represents a current at the other end of the tissue segment;

a first current DAC configured to adjust current at the one end of the tissue segment based on the pre-tissue DAC-code;

a second current DAC configured to adjust current at the other end of the tissue segment based on the post-tissue DAC-code; and

a digital comparator for comparing the pre-tissue DAC-code and the post-tissue DAC code, such that if the comparator detects an absolute difference greater than a desired tolerance, an indication is provided that current leakage is occurring.

18. The implantable device according to claim 17, wherein the implantable device is an implantable hearing device.

19. The implantable device according to claim 18, wherein the implantable device is a cochlear implant.

20. The implantable device according to claim 17, further comprising:

a stimulation-power rail; and

a counterpart stimulation-ground rail;

a first analog comparator configured to compare the stimulation-power rail voltage against a first desired value and thereby produce a first adjustment signal; and

a second analog comparator configured to compare the stimulation-ground rail voltage against a second desired value and thereby produce a second adjustment signal;

wherein the first DAC-code generator is further configured to generate the pre-tissue DAC-code based on the first adjustment signal; and

wherein the second DAC-code generator is further configured to generate the post-tissue DAC-code based on the second adjustment signal.